Surrey Heartlands

Joint Formulary & PAD

Amikacin liposomal - Bacterial lung infection (non-cystic fibrosis)

You are here : Home > Formulary Search > Amikacin liposomal - Bacterial lung infection (non-cystic fibrosis)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Inhalation
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NHSE
Restrictions / Comments :
Important
Follow local guidelines on the use of antimicrobials

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Amikacin liposomal
Indication :
Bacterial lung infection (non-cystic fibrosis)
Group Name :
Keywords :
antibiotic, antibacterial, aminoglycoside
Brand Names Include :
Arikayce Liposomal
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Amikacin liposomal is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Bacterial lung infection (non-cystic fibrosis).

  • No records returned.

Committee Recommendations (1)

22 Feb 21 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

This drug is currently not on the APC workplan. The APC will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Please contact your local CCG Medicines Management team OR formulary pharmacist at your acute trust, if you wish to make a submission. 
This drug / device has not yet been evaluated by NICE or the Surrey and North West Sussex Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing this drug.